Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
- Nam H. Dang
- , Luis Fayad
- , Peter McLaughlin
- , Jorge E. Romaguara
- , Fredrick Hagemeister
- , Andre Goy
- , Sattva Neelapu
- , Felipe Samaniego
- , Pamela L. Walker
- , Michael Wang
- , Maria A. Rodriguez
- , Ann T. Tong
- , Barbara Pro
Research output: Contribution to journal › Article › peer-review
33
Link opens in a new tab
Scopus
citations